Senestech (SNES) Expected to Post Quarterly Earnings on Monday

by · The Cerbat Gem

Senestech (NASDAQ:SNES – Get Free Report) is anticipated to announce its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect Senestech to post earnings of ($0.31) per share and revenue of $0.92 million for the quarter. Individuals can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Monday, November 9, 2026 at 5:00 PM ET.

Senestech (NASDAQ:SNES – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.02. The firm had revenue of $0.77 million during the quarter, compared to analyst estimates of $0.60 million. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%. On average, analysts expect Senestech to post ($1.27) EPS for the current fiscal year and ($1.07) EPS for the next fiscal year.

Senestech Stock Performance

Shares of Senestech stock opened at $1.08 on Monday. The stock’s fifty day moving average is $0.85 and its two-hundred day moving average is $1.49. The company has a market capitalization of $5.86 million, a PE ratio of -0.79 and a beta of 0.25. The company has a quick ratio of 5.81, a current ratio of 6.78 and a debt-to-equity ratio of 0.02. Senestech has a 52 week low of $0.55 and a 52 week high of $3.61.

Insider Activity

In other news, major shareholder Glenbrook Capital Management acquired 28,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 28th. The shares were bought at an average price of $0.97 per share, with a total value of $27,160.00. Following the completion of the purchase, the insider directly owned 2,194,973 shares in the company, valued at $2,129,123.81. This trade represents a 1.29% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders purchased a total of 1,145,169 shares of company stock valued at $842,773 in the last ninety days. 2.20% of the stock is currently owned by insiders.

Analyst Ratings Changes

Separately, Weiss Ratings cut shares of Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock presently has an average rating of “Sell”.

Read Our Latest Report on SNES

About Senestech

(Get Free Report)

SenesTech, Inc is a biotechnology company focused on developing fertility-control technologies for managing animal populations. The company’s approach is designed to reduce reproduction rather than rely solely on lethal control methods, with applications primarily in rodent management.

SenesTech’s principal product is ContraPest, a liquid bait designed to reduce fertility in rats by affecting reproductive function in both male and female animals. The product is intended for use in commercial, municipal and other settings where rat populations pose sanitation, health or property risks.

Featured Articles